EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized Trial

Anthony C Nichols iD, Julie Theurer iD, Eitan Prisman iD, Nancy Read, Eric Berthelet, Eric Tran, Kevin Fung, John R de Almeida iD, Andrew Bayley, David P Goldstein, Michael Hier, Khalil Sultanem und 20 weitere

Journal of Clinical Oncology · 2024-12 · 42 (34) · 4023-4028

DOI: 10.1200/jco.24.00119 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Oncology, 2024-12. Verfasst von Anthony C Nichols und 31 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Western University, London, ON, Canada. Hauptthemen laut MEDLINE: Robotic Surgical Procedures, Oropharyngeal Neoplasms, Quality of Life. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy (RT) and transoral robotic surgery (TORS) are both curative-intent treatment options for oropharyngeal squamous cell carcinoma (OPSCC). Herein, we report the final outcomes of the ORATOR trial comparing these modalities, 5 years after enrollment completion. We randomly assigned 68 patients with T1-2N0-2 OPSCC to RT (with chemotherapy if node-positive) versus TORS plus neck dissection (± adjuvant RT/chemoradiation). The primary end point was swallowing quality of life (QOL) assessed with the MD Anderson Dysphagia Inventory (MDADI). Secondary end points included overall and progression-free survival (OS, PFS), adverse events (AEs), and other QOL metrics. The primary end point has been previously reported (Nichols 2019). In this report, the median follow-up was 5.1 years (IQR, 5.0-5.3 years). MDADI total scores converged by 5 years and were not significantly different across the follow-up period ( P = .11). EORTC QLQ-C30 and H&N35 scores demonstrated differing profiles, including worse dry mouth in the RT arm ( P = .032) and worse pain in the TORS arm ( P = .002). Grade 2-5 AE rates did not differ between arms (91% [n = 31] v 97% [n = 33] respectively, P = .61), with more neutropenia and hearing loss in the RT arm, and more dysphagia and other pain in the TORS arm based on grades 2-5 (all P < .05). There were no differences in OS or PFS. In conclusion, toxicity and QOL profiles differ in some domains between RT and TORS, but oncologic outcomes were excellent in both arms. Choice of treatment should remain a shared decision between the patient and their providers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Robotic Surgical ProceduresOropharyngeal NeoplasmsQuality of LifeHumansMaleFemaleMiddle AgedAgedNeck DissectionSquamous Cell Carcinoma of Head and NeckDeglutition Disorders

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, Western University, London, ON, Canada.
  • School of Communication Sciences and Disorders, Western University, London, ON, Canada.
  • Department of Otolaryngology, University of British Columbia, Vancouver, BC, Canada.
  • Division of Radiation Oncology, Western University, London, ON, Canada.
  • Department of Radiation Oncology, University of British Columbia, Vancouver, BC, Canada.
  • Department of Otolaryngology-Head and Neck Surgery, University Health Network, University of Toronto, Toronto, ON, Canada.

ORCID-Profile: Anthony C Nichols, Julie Theurer, Eitan Prisman, John R de Almeida, Suren Krishnan, Hien Le, S Danielle MacNeil, Eric Winquist, Stephanie Johnson-Obaseki, Bret Wehrli, David A Palma

Zitieren

APA

Nichols, A. C., Theurer, J., Prisman, E., Read, N., Berthelet, E., Tran, E., Fung, K., de Almeida, J. R., Bayley, A., Goldstein, D. P., Hier, M., Sultanem, K., Richardson, K., Mlynarek, A., Krishnan, S., Le, H., Yoo, J., MacNeil, S. D., Winquist, E., …, & Palma, D. A. (2024). Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized Trial. Journal of Clinical Oncology, 42(34), 4023-4028. https://doi.org/10.1200/jco.24.00119

Vancouver

Nichols AC, Theurer J, Prisman E, Read N, Berthelet E, Tran E, et al. Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized Trial. Journal of Clinical Oncology. 2024;42(34):4023-4028. doi:10.1200/jco.24.00119

BibTeX
@article{Nichols2024,
  author = {Nichols, Anthony C and Theurer, Julie and Prisman, Eitan and Read, Nancy and Berthelet, Eric and Tran, Eric and Fung, Kevin and de Almeida, John R and Bayley, Andrew and Goldstein, David P and Hier, Michael and Sultanem, Khalil and Richardson, Keith and Mlynarek, Alex and Krishnan, Suren and Le, Hien and Yoo, John and MacNeil, S Danielle and Winquist, Eric and Hammond, J Alex and Venkatesan, Varagur and Kuruvilla, Sara and Warner, Andrew and Mitchell, Sylvia and Chen, Jeff and Johnson-Obaseki, Stephanie and Odell, Michael and Corsten, Martin and Parker, Christina and Wehrli, Bret and Kwan, Keith and Palma, David A},
  title = {Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized Trial},
  journal = {Journal of Clinical Oncology},
  year = {2024},
  volume = {42},
  number = {34},
  pages = {4023--4028},
  doi = {10.1200/jco.24.00119}
}
Kostenlos starten →